Digital intervention for adolescents with ADHD
Feasibility Trial of a Guided Internet-delivered Intervention for Adolescents with ADHD
NA · Haukeland University Hospital · NCT06711224
This study is testing a new online program for teenagers with ADHD to see if it helps them manage their symptoms better with support from a therapist.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 13 Years to 16 Years |
| Sex | All |
| Sponsor | Haukeland University Hospital (other) |
| Locations | 1 site (Bergen) |
| Trial ID | NCT06711224 on ClinicalTrials.gov |
What this trial studies
This feasibility trial investigates a guided digital intervention designed for adolescents aged 13-16 with ADHD. Over a 6-week period, participants will engage in a digital program with weekly therapist contact, while both adolescents and their parents complete self-report questionnaires at various stages. The study aims to assess recruitment, adherence, credibility, satisfaction, and preliminary clinical outcomes using a person-based approach to ensure the intervention is user-centered and effective.
Who should consider this trial
Good fit: Ideal candidates are adolescents aged 13-16 with a diagnosis of ADHD whose parents are willing to participate.
Not a fit: Patients with other primary diagnoses or significant comorbid psychiatric disorders may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could provide an accessible and effective treatment option for adolescents with ADHD.
How similar studies have performed: While there is limited data on similar digital interventions for ADHD, the approach is innovative and may offer new insights into treatment options.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: 1. 13-16 years 2. a diagnosis of ADHD 3. parents are willing to participate in answering questionnaires pre, during, post and follow-up 4. stable medication during the study period 5. participant and parents can read, write and speak Norwegian 6. access to mobile phone and internet. Exclusion criteria: 1. Other primary diagnosis than ADHD (e.g. Autism, intellectual disabilities, severe conduct disorder) 2. clinically significant comorbid psychiatric disorder requiring treatment (e.g. major depression, severe anxiety, suicidal ideation, eating disorder) 3. follows another psychological treatment or intend to start treatment during the intervention period 4. do not follow a regular school plan (e.g. frequently with days away from school/class with different educational content than their peers).
Where this trial is running
Bergen
- Haukeland University Hospital — Bergen, Norway (RECRUITING)
Study contacts
- Principal investigator: Tine Nordgreen, PhD — Haukeland University Hospital
- Study coordinator: Emilie Nordby, MA
- Email: emilie.sektnan.nordby@helse-bergen.no
- Phone: 55975000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: ADHD